Waters Corporation (WAT)
Market Cap | 21.24B |
Revenue (ttm) | 2.91B |
Net Income (ttm) | 622.64M |
Shares Out | 59.38M |
EPS (ttm) | 10.48 |
PE Ratio | 34.15 |
Forward PE | 28.30 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 686,784 |
Open | 343.39 |
Previous Close | 344.71 |
Day's Range | 340.62 - 358.04 |
52-Week Range | 273.60 - 393.38 |
Beta | 0.97 |
Analysts | Hold |
Price Target | 363.92 (+1.72%) |
Earnings Date | Nov 1, 2024 |
About WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies... [Read more]
Financial Performance
In 2023, Waters's revenue was $2.96 billion, a decrease of -0.52% compared to the previous year's $2.97 billion. Earnings were $642.23 million, a decrease of -9.26%.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is $363.92, which is an increase of 1.72% from the latest price.
News
Waters Corporation to Present at the Evercore 2024 HealthCONx Conference
MILFORD, Mass. , Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufac...
Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness
News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enab...
Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates
Shares of Waters Corp. (WAT) surged nearly 20% on Friday, delivering the top daily performance in the S&P 500 after the company reported third-quarter sales and earnings that topped analysts' projecti...
S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce a...
Waters Corporation (WAT) Q3 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Of...
Waters Corp raises annual profit forecast on higher demand for lab equipment
Waters Corp raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug developm...
Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results
Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All r...
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and inn...
New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing
News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer ...
Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call
MILFORD, Mass. , Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m.
Waters Corp.: Embedded Expectations High Under Present Conditions
Waters continues to present with high-quality business characteristics, including high returns on capital employed and loads of freely available cash. Embedded expectations remain exquisitely high, ca...
Waters Corporation Appoints Heather Knight to Board of Directors
MILFORD, Mass. , Aug. 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024.
These Analysts Revise Their Forecasts On Waters After Q2 Results
Waters Corporation WAT reported upbeat second-quarter earnings, but lowered its FY24 outlook on Wednesday.
Waters Corporation (WAT) Q2 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Offic...
Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results
Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40; earnings exceeded guidance with non-GAAP EPS of $...
Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs
News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competitor capillary DSC technologiesi. St...
Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call
MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8:00 a.m.
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
News Summary: Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromisi...
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification
News Summary: Waters becomes the first vendor to obtain ACT™ Ecolabel Certification for 42 of its liquid chromatography columns, providing independent validation of the environmental impact of Waters ...
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
MILFORD, Mass. , May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
News Summary: ACQUITY™ QDa™ II Mass Detector enhances confidence in routine compound identification using the specificity of mass analysis to boost efficiency, robustness, and productivity in LC-UV se...
Waters Corporation (WAT) Q1 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Caspar Tudor - Director, IR Udit Batra - President, CEO & Director Amol Chaubal - SVP & CFO ...
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results
Highlights Sales of $637 million at the high-end of guidance, declined 7% as reported and 9% in organic constant curren cy GAAP EPS of $1.72; earnings well above guidance, with non-GAAP EPS of $2.21 O...
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
News Summary: New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. Reduces problematic no...